Alan Leviton1, Elizabeth N Allred2, Raina N Fichorova3, T Michael O'Shea4, Lynn A Fordham4, Karl K C Kuban5, Olaf Dammann6. 1. Boston Children's Hospital, and Harvard Medical School, Boston, MA, USA. Electronic address: alan.leviton@childrens.harvard.edu. 2. Boston Children's Hospital, and Harvard Medical School, Boston, MA, USA. 3. Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 4. University of North Carolina, Chapel Hill, NC, USA. 5. Boston Medical Center and Boston University School of Medicine, Boston, MA, USA. 6. Tufts University School of Medicine, Boston, MA, USA.
Abstract
AIM: To assess to what extent the blood concentrations of proteins with neurotrophic and angiogenic properties measured during the first postnatal month convey information about the risk of sonographically-identified brain damage among very preterm newborns. METHODS: Study participants were 1219 children who had a cranial ultrasound scan during their stay in the intensive care nursery and blood specimens collected on 2 separate days at least a week apart during the first postnatal month. Concentrations of selected proteins in blood spots were measured with electrochemiluminescence or with a multiplex immunobead assay and the risks of cranial ultrasound images associated with top-quartile concentrations were assessed. RESULTS: High concentrations of multiple inflammation-related proteins during the first 2 postnatal weeks were associated with increased risk of ventriculomegaly, while high concentrations of just 3 inflammation-related proteins were associated with increased risk of an echolucent/hypoechoic lesion (IL-6, IL-8, ICAM-1), especially on day 7. Concomitant high concentrations of IL6R and bFGF appeared to modulate the increased risks of ventriculomegaly and an echolucent lesion associated with inflammation. More commonly high concentrations of putative protectors/repair-enhancers did not appear to diminish these increased risks. CONCLUSION: Our findings provide support for the hypothesis that endogenous proteins are capable of either protecting the brain against damage and/or enhancing repair of damage.
AIM: To assess to what extent the blood concentrations of proteins with neurotrophic and angiogenic properties measured during the first postnatal month convey information about the risk of sonographically-identified brain damage among very preterm newborns. METHODS: Study participants were 1219 children who had a cranial ultrasound scan during their stay in the intensive care nursery and blood specimens collected on 2 separate days at least a week apart during the first postnatal month. Concentrations of selected proteins in blood spots were measured with electrochemiluminescence or with a multiplex immunobead assay and the risks of cranial ultrasound images associated with top-quartile concentrations were assessed. RESULTS: High concentrations of multiple inflammation-related proteins during the first 2 postnatal weeks were associated with increased risk of ventriculomegaly, while high concentrations of just 3 inflammation-related proteins were associated with increased risk of an echolucent/hypoechoic lesion (IL-6, IL-8, ICAM-1), especially on day 7. Concomitant high concentrations of IL6R and bFGF appeared to modulate the increased risks of ventriculomegaly and an echolucent lesion associated with inflammation. More commonly high concentrations of putative protectors/repair-enhancers did not appear to diminish these increased risks. CONCLUSION: Our findings provide support for the hypothesis that endogenous proteins are capable of either protecting the brain against damage and/or enhancing repair of damage.
Authors: Adel Helmy; Maria-Grazia De Simoni; Mathew R Guilfoyle; Keri L H Carpenter; Peter J Hutchinson Journal: Prog Neurobiol Date: 2011-09-16 Impact factor: 11.685
Authors: Alan Leviton; Stanthia Ryan; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Karl Kuban; Olaf Dammann Journal: Clin Chim Acta Date: 2017-05-11 Impact factor: 3.786
Authors: Rayana Leal Luna; Vanessa R Kay; Matthew T Rätsep; Kasra Khalaj; Mallikarjun Bidarimath; Nichole Peterson; Peter Carmeliet; Albert Jin; B Anne Croy Journal: Mol Hum Reprod Date: 2015-12-07 Impact factor: 4.025
Authors: Marliese Dion Nist; Rita H Pickler; Tondi M Harrison; Deborah K Steward; Abigail B Shoben Journal: Early Hum Dev Date: 2020-05-22 Impact factor: 2.079
Authors: Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann Journal: J Neuroimmune Pharmacol Date: 2018-09-06 Impact factor: 4.147
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Deborah K VanderVeen; T Michael O'Shea; Karl Kuban; Olaf Dammann Journal: Am J Perinatol Date: 2019-01-27 Impact factor: 1.862
Authors: Alan Leviton; Elizabeth N Allred; Olaf Dammann; Robert M Joseph; Raina N Fichorova; T Michael O'Shea; Karl C K Kuban Journal: PLoS One Date: 2019-03-26 Impact factor: 3.240
Authors: Jacqueline T Bangma; Hadley Hartwell; Hudson P Santos; T Michael O'Shea; Rebecca C Fry Journal: Pediatr Res Date: 2020-11-12 Impact factor: 3.756
Authors: T Michael O'Shea; Monica McGrath; Judy L Aschner; Barry Lester; Hudson P Santos; Carmen Marsit; Annemarie Stroustrup; Crisma Emmanuel; Mark Hudak; Elisabeth McGowan; Simran Patel; Rebecca C Fry Journal: Pediatr Res Date: 2022-08-10 Impact factor: 3.953